How much does semaglutide cost without insurance? (2026 guide)

The short answer for 2026: paying cash, you'll see three kinds of price. Brand-name semaglutide still has a list price over $1,000 a month: TrumpRx shows $1,349.02 for Wegovy® and $1,027.51 for Ozempic®. But since the manufacturer pricing agreements announced in November 2025, Novo Nordisk sells both for $349 a month self-pay at most doses, through NovoCare Pharmacy and TrumpRx, with $199 for a new patient's first two monthly fills at the lowest doses. The Wegovy® pill starts at $149 a month. Compounded semaglutide through telehealth programs is priced by each program, and what's included varies.

At Everlon, semaglutide is $129 first month, then $249/mo from month 2, if prescribed. The price includes the provider evaluation, ongoing check-ins and standard shipping, and the monthly price doesn't change when your dose does. (More on why that matters below.)

What actually drives the price

Four things explain almost every price difference you'll see:

1. Brand-name vs. compounded. Brand-name semaglutide (sold as Ozempic® and Wegovy®) is FDA-approved and made by the original manufacturer. Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient when a licensed provider prescribes it. Compounded medications are not FDA-approved. It's a real trade-off, not a trick.

2. What's bundled. Some prices you'll see are for the medication only: the provider visit, follow-ups and shipping are billed separately and add up. Others (including ours) are one all-in monthly price. When comparing, always total it: medication, provider fees, lab work if required, and shipping.

3. Dose. This is the quiet one. Your prescriber decides your dose, and it may change during treatment, and many prices go up as the dose does. Novo Nordisk's own self-pay prices do: the Wegovy® injection is $349 at most doses and $399 for Wegovy® HD 7.2 mg, and Ozempic® is $499 at 2 mg. Some compounded programs charge more at higher doses too. Ask any service directly: "Is the price the same at every dose?" (Ours is.)

4. Introductory prices and commitments. Novo Nordisk's $199 first-fill price for new patients runs through December 31, 2026. Some plans require multi-month prepayment or carry cancellation terms. Read the renewal terms before you start.

2026 cash prices at a glance (checked September 25, 2026)

Prices change and vary by dose and eligibility; check the official pages in the Sources list. A prescription is never guaranteed: a licensed provider determines whether treatment is appropriate for you.

At Everlon, semaglutide is $129 first month, then $249/mo from month 2, if prescribed, with the provider evaluation, check-ins and standard shipping included, at the same monthly price at every dose.

Questions to ask before paying anyone

1. Is a licensed provider actually evaluating me? A real health questionnaire and provider review should happen before any prescription. If a service will "guarantee" you medication before anyone has reviewed your health history, walk away.
2. Which pharmacy fills it? You want a licensed U.S. pharmacy.
3. Is the price the same at every dose? See above: this is where budgets break.
4. What happens if I'm not approved? You shouldn't pay for medication you were never prescribed. (At Everlon, you'll only be charged if treatment is prescribed.)
5. What's the cancellation policy? Month-to-month beats lock-ins.

Can insurance ever help?

Sometimes. Coverage for weight-management medication is inconsistent, often needs prior authorization, and many plans exclude it. One 2026 change worth knowing: Medicare's GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027, covers the Wegovy® injection and pill (and certain other GLP-1s) for a $50 copay per one-month supply, for people with Part D who meet its eligibility criteria, with prior authorization. If you're on Medicare, Medicare.gov lists who qualifies. If you have other coverage, ask your insurer about brand-name options and appeals. Cash-pay exists for everyone the insurance route leaves out, and that's the group we built for.

FAQ

Why is compounded semaglutide cheaper? Pricing is set by the pharmacy and the service rather than a brand list price. The trade-off: compounded medications are not FDA-approved. Understand that difference before choosing. The gap narrowed in 2026, with brand self-pay injections at $349 a month at most doses, so compare the all-in monthly number (medication, provider care and shipping), not just the medication price.

How do brand self-pay prices compare with an all-in program? Do the addition for your situation. The brand self-pay programs sell the medication only: the prescription, dose changes and any follow-up care are arranged and paid for separately. All-in programs bundle them. Whichever way you go, total everything before comparing.

Does the price go up as my dose increases? At many services, and for most brand self-pay prices, yes. At Everlon, no: semaglutide is $249/mo from month 2 at every dose.

Do I need insurance to use Everlon? No. Everlon is cash-pay only: one monthly price, no insurance paperwork, no prior authorizations.

Is a prescription guaranteed? Never, here or anywhere legitimate. A licensed provider reviews your health history and prescribes only when clinically appropriate.

What if it's unavailable in my state? Availability varies by state (see current states). Not all treatments are available in all states.

Sources

• Wegovy® pen — TrumpRx.gov, accessed 2026-09-25
• Ozempic® — TrumpRx.gov, accessed 2026-09-25
• Wegovy® pill — TrumpRx.gov, accessed 2026-09-25
• Wegovy® self-pay offer — NovoCare Pharmacy (Novo Nordisk), accessed 2026-09-25
• FDA approves the Wegovy® pill (December 22, 2025) — Novo Nordisk, accessed 2026-09-25
• US list-price reduction for Wegovy® and Ozempic® (February 24, 2026) — Novo Nordisk, accessed 2026-09-25
• Fact sheet: most-favored-nation pricing agreements (November 6, 2025) — The White House, accessed 2026-09-25
• Weight loss drugs — Medicare.gov, accessed 2026-09-25
• Medicare GLP-1 Bridge — CMS, accessed 2026-09-25

Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. NovoCare and TrumpRx are programs of their respective owners. Everlon is not affiliated with or endorsed by Novo Nordisk or TrumpRx.gov.